SPEAKERS

KEYNOTE SPEAKER: P. Roy Vagelos

PANEL DISCUSSION I: AI AND DATA ON DISCOVERY AND CLINICAL DEVELOPMENT
Paolo Guarnieri – Principal Scientist, Boehringer Ingelheim
Sarah Kramarz – Director of Business Development at Flatiron Health
Aris Baras – SVP, Regeneron and GM, Regeneron Genetics Center
Karen Akinsanya – Chief Biomedical Scientist, Schrodinger
Ramesh Durvasula – VP and Information Officer, Research Labs at Eli Lilly  *Invited
MODERATOR: Coming Soon!

PANEL DISCUSSION II: PRICING AND POLICY
Jeff Berkowitz – CEO, Real Endpoints
Peter Bach – Director, Center for Health Policy and Outcomes, MSKCC
Steve Sands – Vice Chairman Investment Banking and Chairman Global Healthcare Group, Lazard
MODERATOR: Molly Williams, Pfizer

PANEL DISCUSSION III: ROLE OF FOUNDATIONS IN INNOVATION AND DEVELOPMENT
Lynn Voss – CEO, Muscular Dystrophy Association
Louis  DeGennaro – CEO, Leukemia and Lymphoma Society
Todd Sherer, PhD – CEO, Michael J Fox Foundation
Laurie Churchill – Program Officer, Crohn’s Disease Program, Helmsley Charitable Trust
MODERATOR: Linda Malek, Moses & Singer

PANEL DISCUSSION IV: FRONTIERS IN LONGEVITY SCIENCE
Coming Soon!
MODERATOR: Life Biosciences

*Schedule subject to change.